The Valley Desk

NCT00569673 · Interventional trial

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Overall registry status Completed

Phase 2

Conditions Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov